Literature DB >> 24773206

N-acetylcysteine in trichotillomania: a panacea for compulsive skin disorders?

M Taylor1, K Bhagwandas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24773206     DOI： 10.1111/bjd.13080

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  8 in total

1.  Trichoteiromania: Good Response to Treatment with N-Acetylcysteine.

Authors:  Corina Isabel Salas-Callo; Rodrigo Pirmez
Journal:  Skin Appendage Disord       Date:  2019-03-08

Review 2.  The Potential of N-Acetylcysteine for Treatment of Trichotillomania, Excoriation Disorder, Onychophagia, and Onychotillomania: An Updated Literature Review.

Authors:  Debra K Lee; Shari R Lipner
Journal:  Int J Environ Res Public Health       Date:  2022-05-24       Impact factor: 4.614

Review 3.  Pharmacotherapy for trichotillomania.

Authors:  Jacob Hoffman; Taryn Williams; Rachel Rothbart; Jonathan C Ipser; Naomi Fineberg; Samuel R Chamberlain; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2021-09-28

Review 4.  A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Authors:  Marco A Grados; Elizabeth B Atkins; Gabriela I Kovacikova; Erin McVicar
Journal:  Psychol Res Behav Manag       Date:  2015-04-28

5.  Trichotillomania as a Manifestation of Dementia.

Authors:  Pongsatorn Paholpak; Mario F Mendez
Journal:  Case Rep Psychiatry       Date:  2016-10-20

Review 6.  Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines.

Authors:  Cody J Connor
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-04-20

Review 7.  Anxiolytic properties of compounds that counteract oxidative stress, neuroinflammation, and glutamatergic dysfunction: a review.

Authors:  Patrícia Santos; Ana P Herrmann; Elaine Elisabetsky; Angelo Piato
Journal:  Braz J Psychiatry       Date:  2018-10-11       Impact factor: 2.697

Review 8.  The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders.

Authors:  Richard C J Bradlow; Michael Berk; Peter W Kalivas; Sudie E Back; Richard A Kanaan
Journal:  CNS Drugs       Date:  2022-03-22       Impact factor: 6.497
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.